Cel-Sci Corporation (CVM)
NYSE American · Manufacturing · Biological products, (no diagnostic substances)
$1.67−$0.0500 (−2.91%) on the dayAs of the close; data may be delayed.
CVM price, last 12 months
Key stats
- Previous close
- $1.72
- Open
- $1.70
- Day range
- $1.67 – $1.71
- 52-week range
- $0.8900 – $10.83
- Volume
- 36.4K
- Avg volume (20 days)
- 111.2K
- Market cap
- $29.4M
Performance
1W+0.6%
1M+3.7%
3M+50.5%
6M−51.9%
YTD−68.3%
1Y−81.4%
vs S&P 500, 1Y−98.2 pts
Technicals and fundamentals
About Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NYSE American
- Market cap
- $29.4M